Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colonic Neoplasms 10Stomach Neoplasms 3Rectal Neoplasms 3Carcinoma, Hepatocellular 3Neoplastic Cells, Circulating 2Neoplasms 2Lung Neoplasms 2Liver Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Stomach Ulcer 1Prostatic Neoplasms 1Polyps 1Patient Satisfaction 1Pancreatic Neoplasms 1Pain, Postoperative 1Overweight 1Ovarian Neoplasms 1Obesity 1Melanoma 1Hypoxia 1Esophageal Neoplasms 1Endobronchial Metastases 1Emergence Delirium 1Diverticulosis, Colonic 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Cisplatin 161Fluorouracil 135Paclitaxel 127Radiotherapy 125Oxaliplatin 88Carboplatin 72Docetaxel 71Irinotecan 60pembrolizumab 57Leucovorin 57Capecitabine 57Radiation 48Esophagectomy 44Surgical Procedures, Operative 42Drug Therapy 38Neoadjuvant Therapy 28Cetuximab 25Nivolumab 24Bevacizumab 21camrelizumab 20Trastuzumab 20S 1 (combination) 19Chemoradiotherapy 19Magnetic Resonance Spectroscopy 18Epirubicin 16Albumin-Bound Paclitaxel 16Blood Specimen Collection 15tislelizumab 14Taxes 14Radiotherapy, Intensity-Modulated 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Propofol × Gastrointestinal × Clear all
NCT04513808 2024-12-04

Total Intravenous Anesthesia and Recurrence Free Survival

The Cleveland Clinic

Phase 3 Recruiting
1,614 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡